|
|
|
|
Suppliers for
Metformin hydrochloride
|
Properties | | CAS |
1115-70-4 | | Formula |
C4H11N5.HCl | | EINECS |
214-230-6 |
|
|
23 Registered suppliers
| Characters | White granular powder
| | Fineness |
| | Over 20 mesh screen | 85%~100%
| | Over 60 mesh screen | 50%~85%
| | Over 100 mesh screen | 30%~65%
| | Black spots/Impurities | Found no dot and foreign bodies
| | Inentification | Comply
| | Loss on drying | 1.1~1.4%
| | 1-Cyanoguanidine | ≤ 0.02%
| | Content of evenness | RSD≤ 6.0%
| | Content | 90.5~97.4%
| | Total Bacteria | ≤ 1000 cfu/g
| | Total Fungi | ≤ 100 cfu/g
| | Escherichia Coli | Not one present |
| Characters | White granular powder
| | Fineness |
| | Over 20 mesh screen | 85%~100%
| | Over 60 mesh screen | 50%~85%
| | Over 100 mesh screen | 30%~65%
| | Black spots/Impurities | Found no dot and foreign bodies
| | Inentification | Comply
| | Loss on drying | 1.1~1.4%
| | 1-Cyanoguanidine | ≤ 0.02%
| | Content of evenness | RSD≤ 6.0%
| | Content | 90.5~97.4%
| | Total Bacteria | ≤ 1000 cfu/g
| | Total Fungi | ≤ 100 cfu/g
| | Escherichia Coli | Not one present |
| Characters | White granular powder
| | Fineness |
| | Over 20 mesh screen | 85%~100%
| | Over 60 mesh screen | 50%~85%
| | Over 100 mesh screen | 30%~65%
| | Black spots/Impurities | Found no dot and foreign bodies
| | Inentification | Comply
| | Loss on drying | 1.1~1.4%
| | 1-Cyanoguanidine | ≤ 0.02%
| | Content of evenness | RSD≤ 6.0%
| | Content | 90.5~97.4%
| | Total Bacteria | ≤ 1000 cfu/g
| | Total Fungi | ≤ 100 cfu/g
| | Escherichia Coli | Not one present |
| Characters | White granular powder
| | Fineness |
| | Over 20 mesh screen | 85%~100%
| | Over 60 mesh screen | 50%~85%
| | Over 100 mesh screen | 30%~65%
| | Black spots/Impurities | Found no dot and foreign bodies
| | Inentification | Comply
| | Loss on drying | 1.1~1.4%
| | 1-Cyanoguanidine | ≤ 0.02%
| | Content of evenness | RSD≤ 6.0%
| | Content | 90.5~97.4%
| | Total Bacteria | ≤ 1000 cfu/g
| | Total Fungi | ≤ 100 cfu/g
| | Escherichia Coli | Not one present |
| Characters | White granular powder
| | Fineness |
| | Over 20 mesh screen | 85%~100%
| | Over 60 mesh screen | 50%~85%
| | Over 100 mesh screen | 30%~65%
| | Black spots/Impurities | Found no dot and foreign bodies
| | Inentification | Comply
| | Loss on drying | 1.1~1.4%
| | 1-Cyanoguanidine | ≤ 0.02%
| | Content of evenness | RSD≤ 6.0%
| | Content | 90.5~97.4%
| | Total Bacteria | ≤ 1000 cfu/g
| | Total Fungi | ≤ 100 cfu/g
| | Escherichia Coli | Not one present |
Molecular Formula: C4H12ClN5 Molecular Weight: 165.62 Hazard Symbols: Xn,T,F UN Number: UN1230 - class 3 - PG 2 - Methanol, solution WGKGermany: 3 HS Code: 29252900
More details are to be found here
PRODUCT PURPOSE:
Metformin HCL is the standard first line treatment for Type 2 Diabetes, a disease that is expected to grow by 50% until 2045 worldwide and affect more than 700 million people.
The global market for Metformin is expected to grow with a CAGR of 4-6% on an annual basis.
UNIQUE:
API with low levels of residual solvent of impurity. Provide customized particle size distribution for customers. At the same time to provide customers with after-sales preparation production technical support, to achieve the seamless change of API suppliers.
PRODUCT PURPOSE:
Metformin HCL is the standard first line treatment for Type 2 Diabetes, a disease that is expected to grow by 50% until 2045 worldwide and affect more than 700 million people.
The global market for Metformin is expected to grow with a CAGR of 4-6% on an annual basis.
UNIQUE:
API with low levels of residual solvent of impurity. Provide customized particle size distribution for customers. At the same time to provide customers with after-sales preparation production technical support, to achieve the seamless change of API suppliers.
PRODUCT PURPOSE:
Metformin HCL is the standard first line treatment for Type 2 Diabetes, a disease that is expected to grow by 50% until 2045 worldwide and affect more than 700 million people.
The global market for Metformin is expected to grow with a CAGR of 4-6% on an annual basis.
UNIQUE:
API with low levels of residual solvent of impurity. Provide customized particle size distribution for customers. At the same time to provide customers with after-sales preparation production technical support, to achieve the seamless change of API suppliers.
PRODUCT PURPOSE:
Metformin HCL is the standard first line treatment for Type 2 Diabetes, a disease that is expected to grow by 50% until 2045 worldwide and affect more than 700 million people.
The global market for Metformin is expected to grow with a CAGR of 4-6% on an annual basis.
UNIQUE:
API with low levels of residual solvent of impurity. Provide customized particle size distribution for customers. At the same time to provide customers with after-sales preparation production technical support, to achieve the seamless change of API suppliers.
PRODUCT PURPOSE:
Metformin HCL is the standard first line treatment for Type 2 Diabetes, a disease that is expected to grow by 50% until 2045 worldwide and affect more than 700 million people.
The global market for Metformin is expected to grow with a CAGR of 4-6% on an annual basis.
UNIQUE:
API with low levels of residual solvent of impurity. Provide customized particle size distribution for customers. At the same time to provide customers with after-sales preparation production technical support, to achieve the seamless change of API suppliers.
PRODUCT PURPOSE:
Metformin HCL is the standard first line treatment for Type 2 Diabetes, a disease that is expected to grow by 50% until 2045 worldwide and affect more than 700 million people.
The global market for Metformin is expected to grow with a CAGR of 4-6% on an annual basis.
UNIQUE:
API with low levels of residual solvent of impurity. Provide customized particle size distribution for customers. At the same time to provide customers with after-sales preparation production technical support, to achieve the seamless change of API suppliers.
PRODUCT PURPOSE:
Metformin HCL is the standard first line treatment for Type 2 Diabetes, a disease that is expected to grow by 50% until 2045 worldwide and affect more than 700 million people.
The global market for Metformin is expected to grow with a CAGR of 4-6% on an annual basis.
UNIQUE:
API with low levels of residual solvent of impurity. Provide customized particle size distribution for customers. At the same time to provide customers with after-sales preparation production technical support, to achieve the seamless change of API suppliers.
PRODUCT PURPOSE:
Metformin HCL is the standard first line treatment for Type 2 Diabetes, a disease that is expected to grow by 50% until 2045 worldwide and affect more than 700 million people.
The global market for Metformin is expected to grow with a CAGR of 4-6% on an annual basis.
UNIQUE:
API with low levels of residual solvent of impurity. Provide customized particle size distribution for customers. At the same time to provide customers with after-sales preparation production technical support, to achieve the seamless change of API suppliers.
PRODUCT PURPOSE:
Metformin HCL is the standard first line treatment for Type 2 Diabetes, a disease that is expected to grow by 50% until 2045 worldwide and affect more than 700 million people.
The global market for Metformin is expected to grow with a CAGR of 4-6% on an annual basis.
UNIQUE:
API with low levels of residual solvent of impurity. Provide customized particle size distribution for customers. At the same time to provide customers with after-sales preparation production technical support, to achieve the seamless change of API suppliers.
Purity : 97% Smile code : N=C(NC(N)=N)N(C)C.[H]Cl MDL Number : MFCD00012582 MolFormula : C4H12ClN5 MolWeight : 165.6246 Available in stock : 62197.252
More details are to be found here
Purity : 97% Smile code : N=C(NC(N)=N)N(C)C.[H]Cl MDL Number : MFCD00012582 MolFormula : C4H12ClN5 MolWeight : 165.6246 Available in stock : 62197.252
More details are to be found here
Purity : 97% Smile code : N=C(NC(N)=N)N(C)C.[H]Cl MDL Number : MFCD00012582 MolFormula : C4H12ClN5 MolWeight : 165.6246 Available in stock : 62197.252
More details are to be found here
Purity : 97% Smile code : N=C(NC(N)=N)N(C)C.[H]Cl MDL Number : MFCD00012582 MolFormula : C4H12ClN5 MolWeight : 165.6246 Available in stock : 62197.252
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
|
|
|
Privileged suppliers
Last update 2024-06-18
|
details
details
details